《大行報告》大摩升新高教集團(02001.HK)目標價至6.4元 評級「增持」
摩根士丹利發表研報指,新高教集團(02001.HK)以1.52億元人民幣增持廣西學校39%股權,持股增至90%,該學校目前有超過1萬名在校生,預期對公司2021年調整後淨利潤產生約2%的正面影響。公司計劃進一步擴建廣西校區,正在等待政府批准。
該行認為,此次收購與公司追求內生增長的戰略一致,管理層透露目前併購市場估值很高,但未來仍會在西南地區尋找機會,亦考慮在廣東及四川自建大學。大摩將2021及2022年的每股盈利預測提高2%,以反映是次收購,目標價由5.6元上調至6.4元,評級「增持」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.